Stevens-Johnson syndrome genetic testing can identify certain inherited risk factors before a drug reaction happens. But it does not predict every case of SJS, and it does not apply to every medication.
At Dunn Sheehan, we often hear from families months after the hospital stay, after the burn-unit care, after the eye damage, after life has already changed. They find one phrase in a medical article and start asking the same painful question: could this have been prevented?
The honest answer is limited. Genetic testing can identify elevated risk in certain drug and ancestry combinations. The clearest example involves the HLA-B*15:02 gene variant and carbamazepine. The latter is a medication linked to a higher risk of SJS/TEN in patients with ancestry from populations where that variant may be present.
What Is HLA-B*15:02?
HLA-B*15:02 is a gene variant tied to immune response. In some patients, that variant can make the body more likely to react severely to carbamazepine.
This is not a general SJS test. It is a specific test for a specific risk pattern. The NCBI review of carbamazepine therapy and HLA genotype explains that testing should happen before administering carbamazepine in patients with ancestry from populations where HLA-B*15:02 may be present.
That is why Stevens-Johnson syndrome genetic testing needs careful explanation. A negative test does not remove every SJS risk. A positive test does not mean a reaction has already happened. It means the prescribing risk has changed before the drug enters the body.
Let’s Talk About the Warning Label
The legal question is not whether a patient should have known to ask for a genetic test. The legal question is whether the drug manufacturer gave clear warning and risk information.
Drug companies have a duty to warn prescribers about serious risks tied to their products. When a genetic testing recommendation matters for safe use, that information belongs in the prescribing label in a way that doctors can understand and apply.
That is where accountability comes in. If a manufacturer knew about a drug-specific genetic risk and failed to communicate testing guidance clearly, the failure is that of the company that supplied (or didn’t supply) the warning.
At Dunn Sheehan, we look at the medication, the label’s language, the safety history, and the timing of your SJM reaction. Our work starts with the same evidence behind our broader review of SJS causes: what drug was taken, when symptoms began, and what warnings existed at that time.
Frequently Asked Questions
Does a positive HLA-B*15:02 test mean I will develop SJS?
No. A positive test after Stevens-Johnson syndrome genetic testing means the risk may be elevated if a person takes a medication tied to that genetic marker. It does not mean SJS has already started. It means the medication being selected deserves extra caution before being prescribed.
If I was not tested, do I have a legal case?
A viable case depends on the drug, the label, the timing, and the severity of the injury. Our team of SJS specialists at Dunn Sheehan reviews whether the manufacturer clearly warned about known testing guidance and whether that warning failure could have changed what happened.
Should my family members ask about genetic testing?
Family members should tell their doctors about any history of SJS or TEN before taking a new medication. A medical provider can decide whether genetic testing is necessary when prescribing drugs. Related medications are not always obvious by name, so your medical history matters.
Speak With Our SJS Litigation Team
Our firm has handled more SJS claims against more drug manufacturers than any other firm in the nation. You can review our SJS case results to see how we prepare these cases.
If you found genetic testing information after an SJS diagnosis, you are not alone. Many families unfortunately learn about testing long after their diagnosis.
We can help you understand whether testing guidance played a role in your case. We review the medical records, the warning label history, and the manufacturer’s responsibility so you do not have to carry that burden alone.
